Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Statins

Statin treatment associated with reduced risk of glaucoma

Researchers discovered that people with any history of statin use had a 15% lower risk of primary open-angle glaucoma compared with never users. 

Receiving statin treatment for five years or more is associated with a 21% reduced risk of primary glaucoma, research published in JAMA Ophthalmology has shown (2 May 2019)[1].

The study took data on self-reported serum cholesterol levels and statin use from three large cohort studies on a total of 136,782 people (113,702 of whom are women) aged 40 years and over. Over 1,485,498 person-years’ follow-up there were 886 cases of incident primary open-angle glaucoma (POAG).

Each 20mg/dL increase in total serum cholesterol was associated with a 7% increased risk of POAG. People with any history of statin use had a 15% lower risk of POAG compared with never users, and those with at least five years’ statin use had a 21% lower risk.

The researchers said the mechanism behind these findings would require additional research, but added that in vitro studies had suggested statins may lower intraocular pressure and have neuroprotective mechanisms.

“As high cholesterol and statin use have been associated with other neurodegenerative diseases, the interrelationships between cholesterol, glaucoma and these outcomes is also fertile ground for further scientific inquiry,” said lead author Jae Hee Kang, an associate epidemiologist at Harvard Medical School, Massachusetts.

Citation: The Pharmaceutical Journal DOI: 10.1211/CP.2019.20206845

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.